Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 4 medicines
Anvisa · 2 medicines · Historical list
AIFA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
22 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Clorazepate Dipotassium | United States | 15MG, 3.75MG, 7.5MG | tablet | Marketed | Able |
| Clorazepate Dipotassium | United States | 15MG, 3.75MG, 7.5MG | capsule | Not marketed | Usl Pharma |
| Clorazepate | Canada | 7.5 MG | Capsule | Marketed | Aa Pharma INC |
| Clorazepate | Canada | 15 MG | Capsule | Marketed | Aa Pharma INC |
| Clorazepate | Canada | 3.75 MG | Capsule | Marketed | Aa Pharma INC |
| Tranxène 5, capsules 5 mg | Netherlands | Capsule, hard | Authorised | Neuraxpharm Netherlands B.V. | |
| Tranxène 10, capsules 10 mg | Netherlands | Capsule, hard | Authorised | Neuraxpharm Netherlands B.V. | |
| Transene | Italy | Capsula rigida | Authorised | Neuraxpharm Italy S.P.A. | |
| Tranxene | United States | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 7.5MG | tablet | Marketed | Ajenat Pharms |
| Tranxène 20 MB, omhulde tabletten 20 mg | Netherlands | Filmomhulde tablet | Authorised | Neuraxpharm Netherlands B.V. | |
| Tranxène 50, omhulde tabletten 50 mg | Netherlands | Filmomhulde tablet | Authorised | Neuraxpharm Netherlands B.V. | |
| Gen-Xene | United States | 15MG, 3.75MG, 7.5MG | tablet | Not marketed | Alra |
| Tranxene | United States | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule | Not marketed | Ajenat Pharms |
| Tranxene SD | United States | 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Ajenat Pharms |
| Novo-Clopate Cap 15MG | Canada | 15 MG | Capsule | Cancelled | Novopharm Limited |
| Novo-Clopate Cap 7.5MG | Canada | 7.5 MG | Capsule | Cancelled | Novopharm Limited |
| Novo-Clopate Cap 3.75MG | Canada | 3.75 MG | Capsule | Cancelled | Novopharm Limited |
| Tranxene Cap 15MG | Canada | 15 MG | Capsule | Cancelled | Abbott Laboratories, Limited |
| Tranxene Cap 7.5MG | Canada | 7.5 MG / CAP | Capsule | Cancelled | Abbott Laboratories, Limited |
| Tranxene Cap 3.75MG | Canada | 3.75 MG | Capsule | Cancelled | Abbott Laboratories, Limited |
| Tranxilene | Brazil | Cancelled | Sanofi - Synthelabo Farmacêutica Ltda | ||
| Tranxilene | Brazil | Cancelled | Sanofi Winthrop Farmaceutica Ltda |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AIFA, Anvisa, CBG-MEB, FDA and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
